Connor Drake, Cierra Buckman, Amanda Brucker, Eugenia McPeek Hinz, Michael Pignone, Huda Shaikha, Abigail Rader, Isa Granados, Benjamin A Goldstein, Ceci Chamorro, Sam Hoeffler, Cathy Wirth, Susan E Spratt
{"title":"Produce Prescription Subsidy for Patients With Diabetes: A Pragmatic Randomized Clinical Trial.","authors":"Connor Drake, Cierra Buckman, Amanda Brucker, Eugenia McPeek Hinz, Michael Pignone, Huda Shaikha, Abigail Rader, Isa Granados, Benjamin A Goldstein, Ceci Chamorro, Sam Hoeffler, Cathy Wirth, Susan E Spratt","doi":"10.1001/jamainternmed.2025.8008","DOIUrl":"10.1001/jamainternmed.2025.8008","url":null,"abstract":"<p><strong>Importance: </strong>Patients with diabetes and food insecurity are at greater risk of adverse health outcomes. Effective strategies to promote healthy food access are urgently needed.</p><p><strong>Objective: </strong>To evaluate the effect of a produce prescription (PRx) program on cardiometabolic health outcomes and health care utilization among patients with diabetes who were at risk of food insecurity.</p><p><strong>Design, setting, and participants: </strong>This 2-arm, pragmatic, randomized clinical trial was conducted in an integrated academic health system in the southeastern US, and patients were recruited from June to August 2023 and followed up for 12 months. Patients were randomly assigned to be offered a PRx (treatment group) or continued to receive usual care (comparison group). Inclusion criteria included a diabetes diagnosis and being at risk for food insecurity. Randomization was stratified by mean hemoglobin A1c (HbA1c) level during the past year (≥8% vs <8%). Data were analyzed from October 2024 to April 2025.</p><p><strong>Intervention: </strong>The PRx arm received a debit card loaded with $80 monthly for up to 12 months. The card was valid to purchase eligible fresh, frozen, or canned fruits, vegetables, and legumes from grocery retailers. Both arms received diabetes self-management educational materials.</p><p><strong>Main outcomes and measures: </strong>Primary outcomes were HbA1c levels and emergency department visits at 12 months following randomization. Secondary outcomes included body mass index, blood pressure, and inpatient visits.</p><p><strong>Results: </strong>Of 9608 patients assessed for eligibility, 2155 provided consent and were randomized and studied. The mean (SD) age was 56 (14) years, 1524 (71%) were female, 112 (5.3%) were Hispanic, 1272 (61%) were non-Hispanic Black, 663 (32%) were non-Hispanic White, and mean (SD) baseline HbA1c levels were 7.48% (1.77%; to convert to the proportion of total hemoglobin, multiply by 0.01). Benefit use was moderate, with only 433 participants (30%) using 80% or more per month. At 12 months, the treatment (n = 1450) and usual care comparison arm (n = 705) participants had an adjusted between-arm difference in HbA1C levels of 0.20 percentage points (95% CI, 0.05%-0.35%), favoring usual care. There were no significant between-group differences in emergency department visits, blood pressure, body mass index, and inpatient visits. Results were similar in the subgroup (n = 651) with elevated HbA1c levels (≥8%).</p><p><strong>Conclusions and relevance: </strong>This randomized clinical trial found that the PRx program did not improve cardiometabolic health or health care utilization at 12 months. A produce prescription subsidy alone did not improve outcomes among patients with diabetes at risk for food insecurity.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT05896644.</p>","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"416-424"},"PeriodicalIF":23.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12910455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Statins for Primary Prevention-The Gap Between Guidelines and Patient Preferences.","authors":"Ilana B Richman, Anna Hung, Timothy S Anderson","doi":"10.1001/jamainternmed.2025.7955","DOIUrl":"10.1001/jamainternmed.2025.7955","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"404-405"},"PeriodicalIF":23.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146201712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Characterization of the International-Born Health Care Workforce in Rural US Communities.","authors":"Manav Midha, Aditi Doiphode, Erin Duffy","doi":"10.1001/jamainternmed.2025.7633","DOIUrl":"10.1001/jamainternmed.2025.7633","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"486-488"},"PeriodicalIF":23.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12865691/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Missed Posterior Myocardial Infarction Leading to Free Wall Rupture.","authors":"Khoa Quy, Dao V Nguyen, Huy Q Dang","doi":"10.1001/jamainternmed.2025.7644","DOIUrl":"10.1001/jamainternmed.2025.7644","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"479-480"},"PeriodicalIF":23.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Future of Nutrition Interventions in Medicaid.","authors":"Kurt Hager, Seth A Berkowitz","doi":"10.1001/jamainternmed.2025.7194","DOIUrl":"10.1001/jamainternmed.2025.7194","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"398-400"},"PeriodicalIF":23.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mark S Iscoe, Rohit B Sangal, Ula Hwang, Terri R Fried, Daniella Meeker, Todd M Conner, Cameron J Gettel, Sarah Follman, Donald S Wright, Arjun K Venkatesh
{"title":"High-Risk Medication Prescriptions Among Older Adults Discharged from the Emergency Department.","authors":"Mark S Iscoe, Rohit B Sangal, Ula Hwang, Terri R Fried, Daniella Meeker, Todd M Conner, Cameron J Gettel, Sarah Follman, Donald S Wright, Arjun K Venkatesh","doi":"10.1001/jamainternmed.2025.7883","DOIUrl":"10.1001/jamainternmed.2025.7883","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"483-486"},"PeriodicalIF":23.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12887836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rodica Pop-Busui, Søren Rasmussen, John E Deanfield, John B Buse, Nikolaus Marx, Sharon L Mulvagh, Silvio E Inzucchi, Johannes F E Mann, Scott S Emerson, Neil R Poulter, Mads D M Engelmann, G Kees Hovingh, Katrine Bayer Tanggaard, Andreas L Birkenfeld, Kim A Connelly, Martin Haluzik, Matthew A Cavender, Monika Kellerer, Pardeep S Jhund, Søren Gregersen, Olav Wendelboe Nielsen, Carolyn S P Lam, Darren K McGuire
{"title":"Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.","authors":"Rodica Pop-Busui, Søren Rasmussen, John E Deanfield, John B Buse, Nikolaus Marx, Sharon L Mulvagh, Silvio E Inzucchi, Johannes F E Mann, Scott S Emerson, Neil R Poulter, Mads D M Engelmann, G Kees Hovingh, Katrine Bayer Tanggaard, Andreas L Birkenfeld, Kim A Connelly, Martin Haluzik, Matthew A Cavender, Monika Kellerer, Pardeep S Jhund, Søren Gregersen, Olav Wendelboe Nielsen, Carolyn S P Lam, Darren K McGuire","doi":"10.1001/jamainternmed.2025.7774","DOIUrl":"10.1001/jamainternmed.2025.7774","url":null,"abstract":"<p><strong>Importance: </strong>Heart failure (HF) is a common complication of type 2 diabetes (T2D). Oral semaglutide reduced the risk of major adverse cardiovascular (CV) events (MACE; comprising CV death, nonfatal myocardial infarction, or nonfatal stroke) in people with T2D in the SOUL trial, but the impact on HF outcomes in these participants is unknown.</p><p><strong>Objective: </strong>To evaluate the effect of oral semaglutide on HF events, MACE, and safety among participants with or without HF at baseline.</p><p><strong>Design, setting, and participants: </strong>This is a secondary analysis of the double-blind, placebo-controlled, event-driven, phase 3b SOUL randomized clinical trial, which was conducted at 444 centers in 33 countries. Participants were enrolled from June 17, 2019, to March 24, 2021, and had T2D and atherosclerotic CV disease and/or chronic kidney disease, stratified according to the presence or absence of HF history at baseline. Data were analyzed from December 2024 to August 2025.</p><p><strong>Intervention: </strong>Once-daily oral semaglutide or placebo in addition to standard of care.</p><p><strong>Main outcomes and measures: </strong>Prespecified composite HF outcome (time to first occurrence of HF hospitalization, urgent HF visit, or CV death).</p><p><strong>Results: </strong>Overall, 9650 participants (median [IQR] age, 66.0 [61.0-72.0] years; 2790 [28.9%] female) were randomized, with a mean (SD) follow-up of 47.5 (10.9) months. Of these participants, 2229 (23.1%) had HF history (991 [10.3%] with preserved ejection fraction, 592 [6.1%] with reduced ejection fraction, and 646 [6.7%] with unknown subtype). For participants with HF at baseline, the hazard ratio (HR) for risk of the composite HF outcome with oral semaglutide vs placebo was 0.78 (95% CI, 0.63-0.96) and was 1.01 (95% CI, 0.84-1.20) in those without HF at baseline (P for interaction = .06). Among participants with HF, the HR was 0.59 (95% CI, 0.39-0.86) in those with preserved ejection fraction and 0.98 (95% CI, 0.70-1.38) in those with reduced ejection fraction. There was no heterogeneity in the risk reduction of MACE with oral semaglutide in participants with HF history (HR, 0.83; 95% CI, 0.68-1.01) or without HF history (HR, 0.86; 95% CI, 0.75-0.98) (P for interaction = .77). Serious adverse event occurrence among participants with HF was similar with oral semaglutide (594 [53.8%]) and placebo (642 [57.1%]).</p><p><strong>Conclusions and relevance: </strong>In this secondary analysis of the SOUL randomized clinical trial, among individuals with T2D, atherosclerotic CV disease, and/or chronic kidney disease, a reduction of HF events was observed with use of oral semaglutide compared with placebo in those with a history of HF, without increasing the risk of serious adverse events. These data support the potential benefit of oral semaglutide in reducing HF events in people with T2D and HF.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov ","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"426-436"},"PeriodicalIF":23.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12865694/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marco H Blanker, Nienke J E Osse, Anne M M Loohuis
{"title":"Urinary Incontinence-If We Would Only Ask.","authors":"Marco H Blanker, Nienke J E Osse, Anne M M Loohuis","doi":"10.1001/jamainternmed.2025.7832","DOIUrl":"10.1001/jamainternmed.2025.7832","url":null,"abstract":"","PeriodicalId":14714,"journal":{"name":"JAMA Internal Medicine","volume":" ","pages":"444-445"},"PeriodicalIF":23.3,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}